ILC populations elaborate a similar cytokine expression pattern with helper T cell subsets Th1, Th2 and Th17. Recent studies indicate that CD25+ILC2 could alleviate atherosclerosis by altering lipid metabolism, whereas the depletion of CD90-expressing ILCs had no influence on atherosclerosis. Thus, these findings raise the question of whether ILC1 cells react on atherosclerosis. Hence, our group attempted to explore the role of ILC1 cells in atherosclerosis. We found that ILC1 cells have a high Th1-like gene expression of T-bet and IFN-c, which is distinct from ILC2, ILC3 or conventional NK (cNK) cells. Moreover, atherosclerotic lesions were greatly reduced in ApoEÀ/ÀRag1À/À mice treated with anti-
| INTRODUCTION
Atherosclerosis (AS) is a chronic inflammation process that leads to a range of clinical consequences, including myocardial infarction, stroke and peripheral artery disease, and is responsible for the leading cause of morbidity and mortality worldwide. 1 The immune system, which includes innate and adaptive immune responses, responds effectively to danger signals in the initiation and progression of AS. 2 To date, the contribution of T cells and myeloid cells (macrophages and dendritic cells) to AS is gradually being explored. [3] [4] [5] However, the role of innate lymphoid cells (ILCs) in AS remains incompletely understood. ILCs are a recently found group of innate immune cells that resemble T cells, according to the transcription factors and secreted cytokines. 6 However, they lack rearranged receptors and depend on both transcriptional repressor Id2 and the common c-chain of the interleukin-2 receptor (IL2Rc). 6, 7 The population of group 1 ILCs (ILC1 cells) are akin to Th1 cells, which are associated with cell-mediated immunity and express the transcription factor T-bet, secreting interferon-c (IFN-c). 7 ILC1 cells lack granzyme B, which is found in natural killer (NK) cells, and are largely independent of IL-15Ra, underlying their unique identity
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(ILC3 cells) is dependent on Th17-related transcription factor RORct and cytokines IL-17A, IL-17F and IL-22 and has been recently described as Th17 cells that exert inflammatory and protective effects on epithelial cells. 7 Recently, accumulating studies have shown that ILCs react on various inflammatory disease conditions upon excessive activation. [9] [10] [11] [12] Lin À c-Kit + Sca-1 + cells (ILC2 cells) are instrumental for immunity to invading microbes, such as in controlling infections by helminths and other parasites. 11, 13 CD25-expressing ILC2 cells could indirectly attenuate AS via low-density lipoprotein cholesterol mediated by IL-2/ anti-IL-2 complexes. 10 Moreover, IL-23-activated ILC3 cells could provide protection during the acute phase of Citrobacter rodentium-induced colitis. 14, 15 Although ILC subsets with equivalent properties to Th1, Th2 and Th17 cells have now been identified, the importance of these ILC subsets in AS has not yet been well characterized. To date, most of the references are pointing to the population of ILC2 cells. 10, 11, 13 ILCs are similar to T cell patterns, and we consider that ILC1 cells would contribute to AS. Furthermore, factors that regulate the balance of ILC subsets in AS remain unclear. Toll-like receptor 4 (TLR4) has a critical role in initiating inflammation and is widely expressed on many immune cells (T cells, macrophages and DCs). 16 In the present study, we demonstrated that Lin-CD127+ST2-c-kit-ILC1 cells express TLR4. BACH2, a 92-kDa transcription factor of BTB and CNC homology 1, has been shown to prevent inflammatory diseases by controlling the balance between tolerance and immunity via the regulation of CD4+ T cell differentiation. 17 The authors have revealed that TLR4 can reduce BACH2 expression to mediate CD4+ T cell differentiation in AS. 18 The expression level of BACH2 was downregulated and the expression level of TLR4 was significantly upregulated in peripheral blood mononuclear cells (PBMCs) of patients with acute coronary syndrome (ACS), with significantly higher concentrations of serum oxLDL, cytokines of TH1 cells, TH2 cells and TH17 cells, and low levels of cytokines in Treg cells. A significantly negative correlation exists between BACH2 and TLR4 in patients with coronary artery disease (CAD). In this study, we explore the hypothesis that the high percentage of Lin-CD127+ST2-c-kit-ILC1 cells that accumulate in lesions of AS may be deleterious. In addition, we determined whether AS danger signals such as oxLDL may mediate the decrease in BACH2 expression in a TLR4-dependent manner, which is an effect associated with activated IFN-c-producing Lin-CD127+ST2-c-kit-ILC1 cells that ultimately promote the development of AS. 
| Mice
ApoEÀ/À mice on a C57BL/6 background were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Rag1À/À mice and TLR4À/À mice on a C57BL/6 background were purchased from the Nanjing Biomedical Research Institute of Nanjing University. ApoEÀ/À mice and Rag1À/À KO mice or TLR4À/À KO mice were crossbred for 10 generations to generate ApoEÀ/ÀRag1À/À DKO or ApoEÀ/À TLR4À/À DKO mice. To obtain whole-ILC1 (ILC1s and cNK cells)-depleted mice, ApoEÀ/ÀRag1À/À DKO mice were intravenously administered with 50 lg of anti-NK1.1 mAb (#108702; BioLegend, San Diego, CA, USA) at the age of 6 weeks, once a day, for 6 days. After 1-week recovery, the ILC1 (ILC1s and cNK cells)-depleted mice were transferred with ILC1s isolated from TLR4À/À or TLR4+/+ mice. To obtain cNK cell-depleted mice, antimouse IL-15R mAb (1 lg/g of body weight; eBioscience, San Diego, CA) was injected via the vein. 8 For ApoEÀ/À, ApoEÀ/ÀRag1À/À DKO mice, ILC1 cell-depleted mice and cNK cell-depleted mice, ILC1-depleted mice received Lin-CD127+ST2-c-kit-ILC1 cells from TLR4À/À or TLR4+/ + mice (8 weeks of age), all were fed with a high-fat diet (HFD) (5TJN from TEST Diets; 40% kcal from fat, 0.15% cholesterol) or standard diet (as control groups) for an additional 12 weeks. Then, mice were euthanized for analysis. This study was reviewed and approved by the Institutional Animal Care and Use Committee of Huazhong University of Science and Technology for Medical Sciences.
| Tissue preparation and morphometric determination of AS
Mice were anaesthetized with chloral hydrate before euthanasia. The animals were sacrificed after 20 weeks, and blood was collected via cardiac puncture into heparin-coated tubes. The heart and descending aorta were excised and fixed in DPBS/4% formalin/30% sucrose overnight before being mounted in OCT medium and frozen at À70°C. Aortic sinus consequent cryosections (10 lm) were stained with Oil Red O. For the quantitative analysis of AS, the per cent lesion area in each of the 5 sections from each mouse was obtained.
En face preparations of the descending aorta were washed with distilled water, and en face analysis of the descending aorta was performed after staining the descending aorta with Oil Red O. The area of the plaque was measured using Image-Pro Plus 6.0, Media Cybernetics, Rockville, USA.
| Isolation of cells
Different models of mice were anaesthetized, and their vasculature was perfused by cardiac puncture with PBS containing 20 U/mL of heparin to remove blood from all vessels. Under a dissection microscope, the whole aortas were carefully harvested by pulling off all adipose tissues and collecting all aortic layers, including the adventitia. Harvested aortas were microdissected and digested with 125 U/mL of collagenase type XI, 60 U/mL of hyaluronidase type I, 60 U/mL of DNase1 and 450 U/mL of collagenase type I (all enzymes were obtained from Sigma-Aldrich) in PBS containing 20 mM of HEPES at 37°C protected from light for 1 hour. A cell suspension was obtained by mashing the aorta through a 70-lm strainer. Cells were incubated with Abs and detected by flow cytometry (BD FACSAria TM III). Then, the data were analysed using FLOWJO software (Tree Star Inc., Ashland, OR, USA). For sorting by flow cytometry, spleen mononuclear cell samples were depleted of T cells, B cells and NK cells by labelling with FITC-conjugated anti-Lin (described above) plus anti-FITC microbeads (Miltenyi).
| ILC1 adoptive transfer
Before transferred, anti-NK1.1-treated ApoEÀ/ÀRag1À/À DKO mouse splenocytes were stained with purified NK1.1 (clone PK136) or mouse IgG2a isotype control, followed by anti-mouse IgG2a FITC to ensure the anti-NK1.1 antibody was cleared. Then, the sorting cells were intravenously injected into the recipients, anti-NK1.1-treated ApoEÀ/ÀRag1À/À DKO mice. Lin-CD127+ST2-c-kit-ILC1 cells (1 9 10 6 cells) were sort-purified from the spleen of ApoEÀ/À KO or ApoEÀ/ÀTLR4À/À DKO mice and injected into the tail vein of 8-to 10-week-old anti-NK1.1-treated ApoEÀ/ÀRag1À/À DKO mice. The recipient mice were provided with a high-fat diet after injection for 12 weeks. Mice were sacrificed, and plasma samples were collected for cholesterol measurement.
| RNA extraction and real-time RT-PCR
Cells (approximately 10 6 ) were harvested from spleens, and total RNA was isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA), according to the manufacturer's recommendations. RNA concentration and its purity were measured using a spectrophotometer. One microgram of total RNA was reverse-transcribed into cDNA using the RNA PCR Kit (Takara Biotechnology, Kyoto, Japan), and the cDNA was used as a template. Real-time PCR was performed using the Applied Biosystems StepOne Real-Time PCR System (Applied Biosystems, Foster City, CA, USA), according to the manufacturer's protocols. The housekeeping gene GAPDH was used as an internal control for the PCRs. The sequences of the primers are shown in Table 1 . The PCR mixture was prepared using SYBR Green I (Takara Biotechnology), cDNA and the primers, following the manufacturer's protocols. Then, the amount of gene expression was calculated as the difference (MCt) between the Ct value of the target gene and the Ct value of GAPDH. Fold changes in the target gene mRNA were determined using the formula 2ÀMMCt.
| Flow cytometry
After the administration of HFD for 12 weeks, the lymphocytes from the spleen or aorta were isolated with FicollPaque Plus, and RCLB was used to remove the erythrocytes. We use the LIVE/DEAD Fixable Dead Cell Stain (Molecular Probes) during the fixation procedure, to distinguish viable from dead cells. Then, for the detection of ILCs, cells were stained with anti-Lin-FITC antibody (eBioscience, 22-7770), anti-mouse CD127-PE-CF594 antibody (BD, SB/199), antimouse CD117-PECY7 antibody (BD, 2B8) and anti-mouse ST2-PE antibody (R&D, 245707), according to the manufacturer's instructions. Flow cytometric acquisition was performed using FACSAria TM III (BD Immunocytometry Systems, San Jose, CA, USA), and all analyses were performed using FLOWJO software (Tree Star Inc).
| Western blot
Equal amounts of proteins were separated on the SDS-PAGE gel and electrophoretically transferred onto the PVDF membrane. After blocking the membrane in TBST containing non-fat milk (5%) for 2 hours at room temperature, the membranes were washed 3 times in TBST and incubated overnight with the primary antibody, anti-BACH2 (Sigma; SAB2104356; 1:500) and anti-TLR4 (Santa Cruz, CA, USA). After subsequent washing steps, the membranes were incubated with HRP-conjugated secondary antibodies at room temperature for 1 hour and washed 3 times with TBST. The target bands were finally washed and developed with the Super ECL reagent (Thermo Scientific) and semi-quantitatively analysed using densitometric methods.
| Cytokine assay
ILC1 cytokine secretion (IFN-c, IL-1b and IL-6) in the supernatant obtained from oxLDL (25, 50 lg/mL)/LPS (100, 1000 ng/mL)-stimulated ILC1 cells was determined by ELISA. All commercial kits were purchased from R&D Systems (Minneapolis, MN, USA). Each sample was tested in triplicate.
| Lipid profile
Mice were fasted overnight at the age of 20 weeks. Blood samples were collected by cardiac puncture at the time of euthanasia, and the serum was separated. The concentrations of total cholesterol, triglycerides and high-density lipoprotein (HDL) cholesterol were measured by enzymatic methods using kits obtained from BioVision (Mountain View, CA).
| Statistical analysis
The results are presented as mean AE standard deviation (SD) of at least 3 repeated analyses. Statistical differences between 2 groups were analysed by Student's t test, and ANOVA was used for the comparison of 3 or more groups. Statistics were calculated using the GRAPHPAD PRISM 5 software package (GraphPad, La Jolla, CA, USA). A P-value <.05 was considered statistically significant.
| RESULTS

| Identification of ILC populations
Increasing studies have demonstrated that ILC subsets can be accounted as the innate equivalents of T cell subsets, which have the same pattern of transcription factor and cytokines. 19 In human tissues, these ILC populations have already been explored. Thus, ILC populations were examined with the characteristics of T cells obtained from the spleens on ApoEÀ/À mice after 12 weeks of HFD. However, as the percentage of cells was very low, data could not be obtained in WT mice with normal diet. Meanwhile, ApoEÀ/À mice could express a comparatively higher ILC population with HFD ( Figure 1A , left lower corner; 0.35% Figure 1A ) and cNK cells which are sorted as CD127-NKp46+. Data are representative of 8 experiments (A) or of at least 3 independent experiments with 1 to 3 mice each. Data are presented as means AESD. NS indicates no difference, **P < .01, ***P < .001 and 9.4%). Gating on CD127+ haematopoietic cells, which lacked markers for haematopoietic precursors (CD34), B cells, T cells or NK cells, or myeloid cells, the Lin-CD127+ST2-c-kit-ILC population was identified (Figure 1A , left lower corner; 0.35% and 9.4%), which expressed IFN-c, IL-1b, IL-6 and genes that encoded T-bet ( Figure GATA-3) . Furthermore, it was observed that the Lin-CD127+ST2+ ILC population ( Figure 1A , right lower corner; 0% and 0.13%) had a high mRNA expression of Th2 markers IL-13, IL-5 and GATA-3 ( Figure 1D ), the Lin-CD127+ST2-c-kit+ILC population ( Figure 1A , left upper corner; 0.03% and 0.78%) expressed IL-17A, and the genes encoded RORct ( Figure 1D ).
| Lin-CD127+ST2-c-kit-ILC1s are similar to Th1 cells
Lin-CD127+ ST2-c-kit-ILC were different from Lin-CD127+ ST2+ ILC2 and Lin-CD127+ ST2-c-kit + ILC3, because they did not express transcripts encoding IL-13 or IL-17 and did not express GATA-3 and RORct (Figure 1D ). After stimulating Lin-CD127+ ST2-c-kit-ILC in vitro, the expression of IFN-c, IL-1b and IL-6 was activated ( Figure 1D ), indicating that the ILC population secreted Th1-associated cytokines. At the same time, Lin-CD127+ ST2-c-kit-ILCs overexpressed Th1-related transcription factor T-bet ( Figure 1D ), compared to Lin-CD127+ ST2+ ILC2 or Lin-CD127+ ST2-c-kit + ILC3. IL-23 was an effective activator of RORct-dependent ILC3 subsets, which could induce IFN-c production. 9, 19 However, IL-23 could not stimulate spleen Lin-CD127+ ST2-ckit-ILCs to secret IFN-c ( Figure 1E ). In the same case, pro-inflammatory cytokine IL-1b could not induce IFN-c expression ( Figure 1E ). In contrast, IL-12 cocultured with Lin-CD127+ ST2-c-kit-ILCs induced more than a 5-fold increase in IFN-c, and enhanced IFN-c activity once cocultured with IL-18 ( Figure 1E ). Furthermore, the amount of IFN-c protein induced by IL-12 plus IL-18 in Lin-CD127+ST2-c-kit-ILCs was similar to that from cNK cells ( Figure 1F ). This Lin-CD127+ST2-c-kit-ILC1 population has not been described before. In previous studies that used different mouse models and locations, the ILC1 cell phenotype was different. [20] [21] [22] No unique markers have been identified to uniquely define these subsets. In addition, in the present AS model, it was found that the Lin-CD127+ST2-c-kit-phenotype did express T-bet, IFN-c, IL-1b and IL-6 and did not express GATA-3, RORct and relative cytokines, which could provide a hint that it could represent ILC1 and resemble TH1 in AS. The above data indicated that the Lin-CD127+ ST2-c-kit-ILC population has similar functional and phenotypic characteristics when compared to Th1 cells. Thus, this population can be defined as "ILC1 cells."
The phenotype of the Lin-CD127+ ST2-c-kit-ILC population expressing T-bet and IFN-c has been identified. However, in NK cells, which belong to the group of ILCs, ILC1 cells also expressed IFN-c and T-bet. Therefore, it is necessary to determine whether these cells are distinct from conventional NK cells. As shown in Figure 1F , Lin-CD127+ ST2-c-kit-ILC1 cells express neither NK cellspecific cytotoxic molecule-specific marker granzyme B nor the necessary IL-15R complex IL-15a receptor fraction, 23 although both ILC1 and NK cells express NK1.1
and ILC1 cells 24, 25 ( Figure 1G ). ILC1 cells express CD127, but lack c-Kit and CD34, suggesting that these cells were also different from NK cells. 26 Thus, although both ILC1 and NK cells have the ability to produce IFN-c, they represent distinct cell types.
| Increased frequency of Lin-
CD127+ST2-c-kit-ILC1s in AS lesions and spleens of HFD ApoEÀ/À mice
To determine whether Lin-CD127+ST2-c-kit-ILC1 cell subsets play a role in chronic inflammation, their percentage during AS progression in ApoEÀ/À mice fed with HFD for 12 weeks was examined. There were no significant differences in mean body weights between ApoEÀ/À and WT mice at the beginning, whereas after 12 weeks of HFD, ApoEÀ/À mice exhibited significant increases in body weight and total cholesterol, as expected (Table 2) . Flow cytometry revealed that the highest percentage of ILCs in the aorta and spleens of both ApoEÀ/À and WT mice comprised the ILC1 cell subsets, whereas a minority of ILCs represented the ILC2 and ILC3 cell subsets. Furthermore, the percentage of ILC1 cell subsets were markedly higher in ApoEÀ/À mice (8%-12%) compared to WT mice, whereas ILC2 cells, which were lower in abundance, also increased in ApoE mice to a lesser degree (4%-6%). These findings suggest that ILC1 cells represent the dominantly present ILC cell subset and may contribute to the development of AS lesion formation (Figure 2 ).
| Impact of Lin-CD127+ST2-c-kit-ILC1 cells on AS plaque formation in mice
ILCs are defined by lymphoid morphology and the absence of markers for myeloid and dendritic cells. In contrast to T or B cells, they lack of recombination activating gene (RAG (Figure 3 ). Moreover, this reduction could be rescued by the adoptive transfer of Lin-CD127+ST2-c-kit-ILC1 cells from ApoE-Rag1À/À DKO mice into ApoE-Rag1À/À DKO mice treated with anti-NK1.1 mAbs (Figure 3 ). There were no significant differences in mean body weight between ApoE-Rag1À/À DKO control mice and ApoE-Rag1À/À DKO mice treated with anti-NK1.1 mAbs or IL-15R mAbs before or after 12 weeks of HFD (Table 2) . Before the transfer, tests revealed that there were no anti-NK1.1 mAbs or anti-IL-15R mAbs that remained. These findings suggest that Lin-CD127+ST2-c-kit-ILC1 cells contribute to AS lesion formation.
| Lin-CD127+ST2-c-kit-ILC1 cells respond to danger signals conveyed by TLR4
In the light of the acknowledged role of TLR4 as a receptor for innate immune response and its involvement in AS, it was hypothesized that TLR4 may play a role in the Lin-CD127+ST2-c-kit-ILC1-mediated induction of AS. All 3 ILC subsets were screened, and it was found that freshly isolated spleen Lin-CD127+ST2-c-kit-ILC1 cells robustly expressed TLR4 (approximately 20-fold), compared with the other 2 groups of ILCs ( Figure 4A,B) . In contrast, other TLRs, such as TLR2, TLR3 and TLR5, were not detected in Lin-CD127+ST2-c-kit-ILC1 cells (data not shown). As Lin-CD127+ST2-c-kit-ILC1 cells can be isolated from AS lesions, they may produce pro-inflammatory cytokines (IFN-c, IL-1b and IL-6) in response to oxLDL, a known trigger for lesion progression. 28 To test this hypothesis, Lin-CD127+ST2-c-kit-ILC1 cells isolated from spleens of ApoEÀ/À mice were challenged with different TLR agonists, and the supernatant IFN-c content was analysed by ELISA. Lin-CD127+ST2-c-kit-ILC1 cells produced more IFN-c, IL-1b and IL-6 when stimulated with oxLDL or the TLR4 agonist LPS. In contrast, there was no induction of IFN-c when stimulated by the TLR2 agonist, Pam3CSK4, or the TLR3 agonist, polyI:C ( Figure 4C ). These results demonstrate that Lin-CD127+ST2-c-kit-ILC1 cells obtained from ApoEÀ/À mice are responsive to danger signals conveyed by TLR4 or oxLDL.
| Adoptive transfer of Lin-CD127+ST2-ckit-ILC1 cells accelerates AS depending on TLR4 expression
To further investigate the role of TLR4 on the Lin-CD127+ST2-c-kit-ILC1-mediated induction of AS, ApoEÀ/À Rag1À/À DKO mice treated with anti-NK1.1 mAbs were used, and adoptive transfer with Lin-CD127+ST2-c-kit-ILC1 cells isolated from ApoEÀ/ÀTLR4À/À mice or ApoEÀ/ÀTLR4+/+ mice was performed. Before the transfer, the percentage and purity of ILC1 cells were detected. As shown in Figure 4D , the percentage of ILC1 cells was high, which reached up to 95.6%. Mice that received Lin-CD127+ST2-c-kit-ILC1 cells from TLR4À/À mice exhibited less AS lesions than mice that received Lin-CD127+ST2-c-kit-ILC1 cells from ApoEÀ/ÀTLR4+/+ mice ( Figure 4E-H) . These data indicate that the ILC1 induction of AS is dependent on TLR4 expression.
| The oxLDL-induced increase in IFN-c expression in ILC1 cells is associated with reduced BACH2 expression
It has been previously shown that increased serum concentrations of oxLDL reduced the expression of BACH2 in patients with ACS by activating TLR4 on PBMCs, which is an effect that results from the increased production of pro-inflammatory cytokines and the decreased production of anti-inflammatory cytokines. 18 Therefore, we investigated whether BACH2 is involved in the activation of Lin- CD127+ST2-c-kit-ILC1 cells following exposure to LPS/ oxLDL. As shown in Figure 5A , exposure to oxLDL/LPS upregulated TLR4 expression in Lin-CD127+ST2-c-kit-ILC1 cells isolated form ApoEÀ/À mice, and oxLDL together with LPS synergistically increased TLR4 expression ( Figure 5A , B). Lin-CD127+ST2-c-kit-ILC1 cells isolated from ApoE KO mice and ApoE-TLR4 DKO mice were treated with different doses of LPS/oxLDL for 24 hours, and the supernatant for IFN-c, IL-1b and IL-6 content was analysed by ELISA. Lin-CD127+ST2-c-kit-ILC1 cells from ApoE KO mice produced more IFN-c, IL-1b and IL-6 when stimulated with TLR4 agonist LPS/oxLDL, compared to ILC1 cells obtained from ApoE-TLR4 DKO mice, and exhibited no induction in IFN-c, IL-1b and IL-6 ( Figure 5C,F) . Furthermore, compared to ILC1 cells from ApoE-TLR4 DKO mice, BACH2 expression was markedly decreased when ILC1 cells from ApoE KO mice were treated with high doses of LPS/oxLDL (Figure 5D , E,G,H). These results demonstrate that Lin-CD127+ST2-ckit-ILC1 cells from ApoEÀ/À mice are responsive to danger signals conveyed by the TLR4/BACH2 pathway.
| DISCUSSION
It is known that the participation of immune responses by T cells is crucial for adaptive immunity via the release of a . C and D, Representative images of atherosclerotic lesions in the aortic sinus and descending aorta sections from ApoEÀ/À mice, ApoE-Rag1 DKO mice, anti-IL-15R-treated or anti-NK1.1-treated ApoE-Rag1 DKO mice, and anti-NK1.1-treated ApoE-Rag1 DKO mice that received ILC1s from ApoEÀ/ÀRag1À/À mice. To achieve ILC1 and cNK cell depletion, ApoE-Rag1 DKO mice were injected with anti-NK1.1 mAbs. To achieve cNK cell depletion, ApoE-Rag1 DKO mice were injected with anti-IL-15R mAbs. E, Quantitative analysis of atherosclerotic lesion burden in aortic rout was performed by Oil Red O staining as described in the Methods section (n = 6-10 mice per group). F, Quantitative analysis of atherosclerotic lesion burden in the aorta was performed by Oil Red O staining as described in the Methods section (n = 6-10 mice per group). Data are representative of more than 3 experiments. Data are presented as means AESD. NS indicates no difference, *P < .05, **P < .01. DKO means ApoE-Rag1 DKO mice complex repertoire of cytokines. Based on distinct cytokine secretion profiles, relative T helper (Th) cell subsets have been defined. For instance, Th1 cells drive type 1 immune responses by producing cytokines such as IFN-c, IL-2 and lymphotoxin-a (LT-a) to drive type 1 immune responses to protect against intracellular pathogens. 29 Recently, it has been uncovered that there are important ILC sources of cytokines in addition to adaptive lymphoid cell sources. ILCs, which lack a specific antigen receptor, are immune cells that can produce an array of effector cytokines in an analogous manner to that of Th cell subsets. 6 Given the production of type 1, type 2 and Th17 cell-associated cytokines, experts have proposed that ILCs can be divided into 3 subsets: ILC1 cells (comprised of ILC1 and NK cells), ILC2 cells (comprised of ILC2 cells) and ILC3 cells (comprised of ILC3 and LTi cells), respectively. 30 ILCs produce cytokines that are also produced by T lymphocytes, which have been previously shown to affect atherosclerosis. 31 However, the influence of each of these 3 ILC subsets to AS has not been well defined. A few studies have implicated that ILCs may be involved in AS. For example, NK cells, a kind of cytotoxic IFN-c-secreting innate cells that are phenotypically related to the ILC1 subset, could accelerate AS lesion development in mice. 32 IL-25-producing and IL-33-producing ILC2 cells have been shown to reduce AS. 33, 34 In addition, it has been shown that transcription factor Id3 could regulate the IL-5 production of LinÀSca1+CD117+CD90+ ILCs present in the aorta of AS mice. 35 Moreover, the expansion of CD25- Figure 1A . C, IFN-c, IL-1b and IL-6 production by splenocyte Lin-CD127+ST2-c-kit-ILC1 sorted by flow cytometry as in Figure 1A and cultured for 3 days in the presence of Pam3CSK4 (500 ng/mL , TLR2 agonist), polyI:C (10 lg/mL, TLR3 agonist), LPS (100 ng/mL) (TLR4 agonist) and oxLDL (25 lg/mL), respectively. D, Flow cytometry analysis of the percentage and purity of ILC1s after cell sorting. Numbers in gate (outlined areas) indicate per cent cells in each. E and G, Representative images of atherosclerotic lesions in the aortic sinus and descending aorta sections from anti-NK1.1-treated ApoE-Rag1 DKO mice and anti-NK1.1-treated ApoE-Rag1 DKO mice that received ILC1s from WT mice or ApoEÀ/ÀTLR4À/À mice. F, Quantitative analysis of atherosclerotic lesion burden in aortic rout was performed by Oil Red O staining as described in the Methods section (n = 6-10 mice per group). H, Quantitative analysis of atherosclerotic lesion burden in the aorta was performed by Oil Red O staining as described in the Methods section (n = 6-10 mice per group). Data are representative of more than 3 experiments. Data are presented as means AESD. NS indicates no difference, *P < .05, **P < .01, ***P < .001 complexes leads to the reduction in AS. 10 However, the role of non-cytotoxic IFN-c-secreting ILC1 cells in AS has not been addressed, even with the balance of ILC1 and ILC2 populations during the progression of the disease. Several subsets of ILC1 cells have been identified, which are located predominantly within non-lymphoid tissues, such as the intestinal mucosa, liver and salivary gland, and in the female reproductive tract. The paucity of specific surface markers and transcription factors for ILC1 cells has made studying these cells difficult. In the present study, we described a distinct Lin-CD127+ST2-c-kit-ILC1 subset in AS mice, which has not been defined before. In Anja's study, 8 the phenotype of intraepithelial type 1 innate lymphoid cells is CD160+NKp46+NK1.1+ cells, but in the present study, ILC1 is Lin-CD127+ST2-c-kit-cells. We cannot detect CD160+NKp46+NK1.1+ cells in our HFD lesion and spleen; in the same way, Lin-CD127+ST2-c-kitcells cannot be found in the epithelium. This means different tissues may have their own specific marker for ILC1. Then, Lin-CD127+ST2-c-kit-ILC1 could be a newest treatment target of atherosclerosis. Lin-CD127+ST2-c-kit-ILC1 cells isolated ex vivo expressed low levels of ILC2-associated factor GATA-3, IL-13 and IL-5, and low expression levels of ILC3-associated factor RORct and IL-17A. Moreover, these ILC1 cells were devoid of IL-15Ra and granzyme B expression, indicating that these cells were distinct from NK cells. In contrast, Lin-CD127+ST2-c-kit-ILC1 cells exhibited a high expression of transcription factor Tbet and Th1-related cytokines (IFN-c, IL-1b and IL-6) and secreted high levels of IFN-c protein induced by IL-12 plus IL-18. In addition, we demonstrated that among all the 3 ILC subsets, ILC1 cells were the dominant ILC subset that accumulated in AS lesions and spleens of HFD-fed ApoEÀ/À mice. Finally, depleting ILC1 attenuated AS plaque formation in ApoEÀ/À mice. Thus, IFN-c-producing Lin-CD127+ST2-c-kit-ILC1 cells in the AS lesion may be considered the innate equivalent of the Th1 subset, in which both significantly contribute to AS lesion progression. We also found that there was a low frequency of ILCs in the spleen of WT mice (fed with normal diet) and an increased frequency of all subsets of ILCs in ApoEÀ/À (fed with normal diet) and WT (fed with HFD) mice. It appears that the diet and the susceptibility to develop AS have different effects on the pre-activation or even recruitment of ILCs into the aorta and spleen. This profound effect needs to be verified through further studies. It has been shown that the body's recognition of signature molecules, which are associated with danger to the organism, could initiate innate immune responses. Normally, these molecules should not be expressed. Once cell injury or death occurs, these would be accessible to the immune system. 36 Several endogenous signals such as oxidized low- In the present study, we found that freshly isolated spleen Lin-CD127+ST2-c-kit-ILC1 cells robustly express TLR4, whereas other TLRs such as TLR2, TLR3 and TLR5 could not be detected in these cells. Moreover, only TLR4 agonists LPS and oxLDL consistently increased proinflammatory cytokine (IFN-c, IL-1b and IL-6) production in Lin-CD127+ST2-c-kit-ILC1 cells, suggesting that these cells may directly respond to oxLDL or LPS. In support of the in vivo role for ILC1 cells in AS, ApoEÀ/ÀRag1À/À DKO depleted of ILC1 cells led to a decrease in AS burden, and the effect was rescued by the adoptive transfer of Lin-CD127+ST2-c-kit-ILC1 cells from ApoEÀ/ÀTLR4+/+ mice, but not from ApoEÀ/ÀTLR4À/À mice. The investigators' previous clinical study 18 demonstrated that TLR4 reduced the expression of transcription factor BACH2 to influence the CD4+ T cell subset activation in patients with ACS. Accumulating studies have similarly shown that BACH2 can suppress CD4+ T cell differentiation to prevent inflammatory disease. 42 The studies of the investigators extend these observations and demonstrate that TLR4 negatively regulates BACH2 expression in ILC1s, which is an effect that may induce the release of IFN-c in a similar manner to CD4+ Th1 cells. In support, the LPS/oxLDL stimulation of Lin-CD127+ST2-c-kit-ILC1 cells from ApoEÀ/À DKO mice, but not ApoEÀ/ÀTLR4À/À DKO mice, increased the elaboration of pro-inflammatory cytokines (IFN-c, IL-1b and IL-6). Importantly, the LPS/oxLDL stimulation of Lin-CD127+ST2-c-kit-ILC1 cells from ApoEÀ/À DKO mice, but not from ApoEÀ/ÀTLR4À/À DKO mice, reduced BACH2. Taken together, these findings demonstrate that Lin-CD127+ST2-c-kit-ILC1 cells respond to atherosclerosis danger signals conveyed by the TLR4/BACH2 signalling pathway, which is an effect that significantly aggravates AS in the early stage. In summary, these observations demonstrate that the Lin-CD127+ST2-c-kit-ILC1 subset accumulates the highest of all 3 ILC subsets in AS. Notably, we found that Lin-CD127+ST2-c-kit-ILC1 cells are responsive to oxLDL and TLR4/BACH2 signalling and ultimately accelerates the development of AS in the early stage via increasing the elaboration of pro-inflammatory cytokines (IFN-c, IL-1b and IL-6). This new identification and role of ILCs in AS will allow a better understanding of the complex interactions between the innate and adaptive immune systems in the development and progression of this disease.
